The search engine found new reagents in the following categories.
SARS-CoV-2
NR-59709
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/CA-Stanford-165_S29/2023 (Lineage HK.3)
|
BEI Level 3
|
April
2024
|
NR-59703
|
SARS-Related Coronavirus 2
SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP49152/2023 (Lineage HV.1)
|
BEI Level 3
|
April
2024
|
NR-55701
|
Spike Glycoprotein (Stabilized) from Human Coronavirus 229E with C-Terminal Histidine and Twin-Strep® Tags, Recombinant from HEK293 Cells
Human Coronavirus
|
BEI Level 1
|
April
2024
|
NR-59471
|
A549-ACE2plusC3 Cell Line
|
BEI Level 2
|
March
2024
|
NR-56466
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Omicron Cross-Reactive (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
March
2024
|
NR-56789
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP28972/2022 (Lineage BA.2.12.1)
|
BEI Level 3
|
March
2024
|
NR-56465
|
Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, B.1.1.529 (Omicron) with C-Terminal Histidine Tag, Recombinant from HEK293 Cells
SARS-Related Coronavirus 2
|
BEI Level 1
|
March
2024
|
NR-55294
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1B3 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
March
2024
|
NR-58700
|
Peptide Array, SARS-Related Coronavirus 2 Non-Structural Protein 12 (NSP12)
SARS-Related Coronavirus 2
|
BEI Level 1
|
March
2024
|
NR-59686
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/CA-AK001/2023 (Lineage FL.1.5.1)
|
BEI Level 3
|
February
2024
|
NR-59615
|
Genomic RNA from SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP47946/2023 (Lineage EG.5.1; Omicron Variant)
SARS-Related Coronavirus 2
|
BEI Level 2
|
February
2024
|
NR-58702
|
Peptide Array, SARS-Related Coronavirus 2 Non-Structural Protein 13 (NSP13)
SARS-Related Coronavirus 2
|
BEI Level 1
|
February
2024
|
NR-58701
|
Peptide Array, SARS-Related Coronavirus 2 Non-Structural Protein 7 (NSP7)
SARS-Related Coronavirus 2
|
BEI Level 1
|
February
2024
|
NR-59693
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/New York/PV96109/2023 (Lineage JN.1; Omicron Variant)
|
BEI Level 3
|
December
2023
|
NR-59638
|
SARS-Related Coronavirus 2
SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MI-UM-10052670540/2023 (Lineage BA.2.86) in VTA Cells
|
BEI Level 3
|
December
2023
|
NR-59500
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP47866/2023 (Lineage GJ.2; Deposited as XBB.2.3.3)
|
BEI Level 3
|
December
2023
|
NR-58917
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 65.3.1 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58919
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 92.1.1 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58914
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 58.2.2 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58912
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 34.2.2 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|